Loading...
XSHE
000989
Market cap1.01bUSD
Jul 10, Last price  
8.16CNY
1D
-1.58%
1Q
-15.57%
Jan 2017
-62.78%
IPO
-27.88%
Name

Jiuzhitang Co Ltd

Chart & Performance

D1W1MN
XSHE:000989 chart
P/E
31.02
P/S
3.13
EPS
0.26
Div Yield, %
3.71%
Shrs. gr., 5y
-0.20%
Rev. gr., 5y
-10.22%
Revenues
2.21b
-6.94%
1,101,092,5951,109,212,0051,122,389,7521,136,226,722609,637,433704,352,540797,598,706871,512,6802,673,798,0433,836,565,8843,162,109,0033,183,694,7893,559,540,9633,784,155,2363,784,155,2353,033,265,8593,033,265,8582,961,017,6512,371,372,8322,206,799,860
Net income
223m
+2.96%
199,893,946148,315,410162,691,134201,779,214322,585,295364,006,010403,316,540471,031,524651,809,790721,419,796336,479,569192,146,823272,309,883270,696,505270,696,512357,985,434357,985,440297,411,080216,202,230222,602,461
CFO
438m
+120.30%
135,961,08381,447,770131,212,474220,921,862185,789,943139,721,17387,775,86528,454,244118,592,670339,026,372612,378,390151,996,083425,861,442851,290,910609,555,035365,912,082499,132,759121,397,805198,958,495438,303,477
Dividend
May 08, 20250.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiuzhitang Co., Ltd. is a Chinese pharmaceutical company specializing in the development and distribution of traditional Chinese, chemical, biological, and health-related medicinal products. Its product portfolio addresses a wide array of health concerns. For instance, cardiovascular and cerebrovascular conditions are treated with offerings like shuxuetong injections, Angong Niuhuang Wan, Danxi granules, and Gastrodia Uncaria. Gynecological issues are targeted by Guizhi Fuling pills, Buxue Shengru granules, and other hemostasis and analgesic preparations. Respiratory ailments can be managed with Schicon, while digestive disorders benefit from products such as Jiaqi Ganzian granules, Jianwei Yuyang tablets, Jienchang Ning, and Chidan yellowing products. Furthermore, the company supplies a comprehensive range of over-the-counter (OTC) medications. These non-prescription drugs support areas including qi and blood nourishment, cardiovascular and cerebrovascular health, urinary system function, pediatric care, women's health, musculoskeletal wellness, respiratory relief, dermatological conditions, nervous system support, ENT treatments, digestive aid, and even tumor-related concerns. Established in Beijing, China, in 1999, Jiuzhitang Co., Ltd. maintains its headquarters there.
IPO date
Jun 28, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT